Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Antiviral consumption data in hospitalized children are limited. We utilized electronic prescribing records to interrogate changes to antiviral use between 2019 and 2024 in a large UK children's hospital. Antiviral usage/cost increased significantly, driven predominantly by anti-cytomegalovirus medications. Pediatric antimicrobial stewardship programs should include antiviral usage and be prioritized in centers caring for children at risk of severe viral infections.

More information Original publication

DOI

10.1097/INF.0000000000005117

Type

Journal article

Publication Date

2025-12-26T00:00:00+00:00

Keywords

antiviral, cytomegalovirus, pediatric, stewardship